Filing Details

Accession Number:
0000899243-22-020666
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-02 16:05:41
Reporting Period:
2022-06-01
Accepted Time:
2022-06-02 16:05:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1724979 Rain Therapeutics Inc. RAIN Pharmaceutical Preparations (2834) 821130967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856682 Avanish Vellanki C/O Rain Therapeutics Inc.
8000 Jarvis Avenue, Suite 204
Newark CA 94560
Chairman And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-01 25,000 $2.29 2,471,627 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.285 to $2.3268. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.